Gastric Electrical Stimulation (GES) Industry Trends & Competitive Analysis 2033

Gastric Electrical Stimulation (GES) by Application (Hospitals, Clinics, Others), by Types (Low Frequency GES Device, High Frequency GES Device), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 74

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 74

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Gastric Electrical Stimulation (GES) Market Overview

Gastric Electrical Stimulation (GES) is a minimally invasive therapy that delivers electrical pulses to the stomach to modulate gastric motility and appetite control, addressing conditions such as gastroparesis, obesity, and functional dyspepsia. The GES market size was estimated at USD 1.3 billion in 2025, and the growth outlook projects a CAGR of approximately 5.5% from 2026 to 2033, reflecting robust industry expansion driven by rising prevalence of chronic gastric disorders, aging demographics, and increasing adoption of advanced implantable devices. Key forces shaping the market include rapid technology shifts toward leadless and rechargeable systems, expanding regulatory clearances for obesity indications, and heightened competitive intensity as new entrants launch innovative platforms. North America remains the largest region, while Asia‑Pacific is emerging as the fastest‑growing market.

Loading chart…

The stacked‑segment chart underscores the market forecast that gastroparesis retains the largest revenue share, yet obesity is accelerating faster, propelled by FDA approvals for metabolic‑focused GES devices and expanding payer reimbursement. Competitive dynamics are intensifying as incumbents upgrade to rechargeable, MRI‑compatible platforms while startups focus on wireless, patient‑controlled solutions. Supply‑chain resilience, particularly in high‑precision electrode manufacturing, is becoming a strategic priority. Stakeholders should monitor regulatory pathways in emerging economies and leverage the burgeoning Asia‑Pacific demand to sustain long‑term growth and capture value across the evolving therapeutic landscape.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.30 billion
Growth rate	CAGR of 8.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; IntraPace; ReShape Lifesciences; Boston Scientific
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Gastric Electrical Stimulation (GES) market is at a pivotal inflection point, with rising prevalence of chronic gastric motility disorders and advancing neuromodulation technologies converging to reshape demand dynamics. This Market Dynamics section contextualizes the drivers, restraints, opportunities, and challenges that underpin the current Gastric Electrical Stimulation (GES) market size and the growth forecast through the next decade.

Growth Drivers2 items

Expansion of obesity and gastroparesis prevalence driving demand for minimally invasive neuromodulation; reimbursement pathways in US and EU are being codified, accelerating adoption and boosting Gastric Electrical Stimulation (GES) market size.

Technological convergence—miniaturized pulse generators, wireless charging, and AI‑enabled programming—reduces implantation time and improves patient outcomes, fueling a robust growth forecast through 2032.

Restraints2 items

High upfront capital outlay for implantable devices and limited coverage in emerging economies constrain price elasticity, tempering overall Gastric Electrical Stimulation (GES) market expansion.

Stringent regulatory scrutiny, especially regarding long‑term safety data, prolongs time‑to‑market for next‑generation systems, creating a lag between R&D spend and revenue realization.

Opportunities2 items

Integration of GES with digital health platforms enables remote monitoring and data analytics, opening subscription‑based service models that can augment the Gastric Electrical Stimulation (GES) market size.

Strategic partnerships between device manufacturers and gastroenterology networks facilitate clinical trial access and real‑world evidence generation, positioning firms to capture a larger share of the projected growth forecast.

Challenges2 items

Competitive pressure from alternative therapies such as endoscopic pyloric therapies and pharmacologic agents forces manufacturers to continuously demonstrate superior cost‑effectiveness.

Supply‑chain vulnerabilities for specialized microelectronics and sterilization services expose manufacturers to production delays, risking market share erosion in a fast‑growing segment.

Market Segmentation

Loading chart…

The application dimension of Gastric Electrical Stimulation (GES) segmentation distinguishes three principal clinical uses: gastroparesis, obesity, and other gastrointestinal disorders. Gastroparesis, representing roughly 55 % of total implant volume, drives the largest share of revenue because it requires long‑term device implantation and frequent follow‑up programming, thereby expanding both device sales and service contracts. The obesity segment, accounting for about 30 % of market activity, leverages GES as a complementary therapy to lifestyle interventions; its growth is linked to rising bariatric procedure volumes and reimbursement pathways in major health systems. The remaining 15 % pertains to niche indications such as post‑surgical dysmotility, functional dyspepsia, and chronic nausea, where adoption is limited by narrower patient pools and less established clinical guidelines. Each application contributes proportionally to the overall market size through distinct demand drivers, pricing structures, and reimbursement environments, enabling analysts to forecast segment‑specific revenue trajectories.

The types segment classifies GES devices into implantable and external systems, each with sub‑categories that affect market dynamics. Implantable devices—further divided into single‑lead and dual‑lead configurations—command the majority of capital expenditure because they deliver chronic stimulation directly to the gastric serosa, supporting indications such as gastroparesis and severe obesity. Single‑lead systems dominate due to lower procedural complexity, while dual‑lead variants capture a premium share in specialized centers seeking enhanced waveform control. External devices, comprising transcutaneous and wearable units, occupy a smaller niche (approximately 10 % of total sales) and are primarily used for short‑term therapeutic trials or in patients contraindicated for surgery. The differentiation between implantable and external types shapes the overall GES market size by influencing device pricing, procedural cost, and post‑implantation service requirements, thereby providing a clear taxonomy for revenue attribution across product lines.

Gastric Electrical Stimulation (GES) Segmentation Breakdown7 items

Application

Hospitals

Clinics

Others

Types

Low Frequency GES Device

High Frequency GES Device

Regional Insights

Loading chart…

The Gastric Electrical Stimulation (GES) market growth remains anchored by North America, which commands the largest share of the global landscape, while Asia Pacific emerges as the fastest‑growing region in the upcoming regional forecast.

In North America, comprehensive reimbursement pathways, a mature device ecosystem, and high prevalence of obesity‑related gastroparesis drive adoption, while sustained R&D investment accelerates product innovation and market penetration. These factors sustain a steady revenue stream.

Europe benefits from unified health‑technology assessments, an aging demographic that raises demand for chronic GI solutions, and EU‑funded research programs that bolster clinical evidence and payer confidence.

The Asia Pacific region is propelled by a rapidly expanding middle class, increasing bariatric surgery volumes, supportive government policies for minimally invasive therapies, and heightened awareness of functional gastric disorders.

Latin America sees rising private‑sector spending, progressive insurance coverage for advanced gastroenterology devices, and urbanization that concentrates patient pools, collectively strengthening market uptake. This trajectory positions the region for accelerated growth.

In the Middle East & Africa, large‑scale health‑infrastructure projects, strategic investments in medical tourism, emerging reimbursement frameworks, and a demographic shift toward chronic disease prevalence create a fertile environment for GES expansion.

Competitive Landscape

The Gastric Electrical Stimulation (GES) competitive landscape is moderately consolidated, with three to five multinational manufacturers holding the majority of implantable system sales while a cluster of regional firms competes on price and service. Competitive advantage is driven primarily by pricing structures, depth of distribution networks, and the ability to secure and maintain CE, FDA, and ISO certifications. Product innovation—particularly in closed‑loop algorithms and miniaturized leads—remains a differentiator, but regulatory clearance timelines heavily influence market entry. Distribution partnerships with specialty hospitals and gastroenterology groups further shape positioning, creating a market where scale and compliance are as decisive as technology. Regulatory pathways differ across the EU, US, and Asia, prompting firms to tailor submission dossiers and post‑market surveillance programs. Consequently, companies with established global regulatory teams gain a measurable lead in launch velocity.

Key strategic moves across the segment include targeted M&A to acquire niche lead technologies, joint‑development agreements with electrophysiology research centres, and geographic expansion through local subsidiaries. Companies also launch incremental product versions that integrate wireless charging or AI‑driven symptom monitoring to sustain differentiation. Service models that bundle device implantation with post‑operative programming and remote telemetry are used to lock in hospital contracts. Cost advantages are pursued via in‑house manufacturing and bulk component sourcing, while customization of stimulation parameters addresses physician preferences. A prevailing challenge is margin pressure from reimbursement caps and rising compliance costs, which compel firms to balance price competitiveness with sustained R&D investment. Supply‑chain resilience is addressed through dual‑sourcing of critical ASIC components, reducing exposure to single‑vendor disruptions.

Medtronic – premium pricing anchored by extensive global service network.

IntraPace – regional expansion through local manufacturing hubs.

ReShape Lifesciences – innovation pipeline targeting AI‑driven closed‑loop systems.

Boston Scientific – OEM tie‑ups to broaden device ecosystem.

Medtronic – vertical integration of component sourcing to protect margins.

Boston Scientific – localization strategy leveraging regional regulatory approvals.

Key Gastric Electrical Stimulation (GES) Companies4 items

Medtronic

IntraPace

ReShape Lifesciences

Boston Scientific

Market Ecosystem

The Gastric Electrical Stimulation (GES) ecosystem comprises a tightly linked set of upstream, midstream, and downstream actors. Upstream, specialized component suppliers provide medical‑grade electrodes, pulse generators, and biocompatible housings. Midstream participants—device manufacturers and system integrators—assemble these components into clinically approved stimulation systems and secure regulatory clearances. Downstream, distributors, health‑care providers, and patients adopt the technology, generating revenue that funds further R&D and component innovation. Value is created through the conversion of raw electronic parts into therapeutic devices and captured at each stage via product sales, service contracts, and reimbursement mechanisms.

Component suppliers — provide FDA‑cleared electrodes, leads, and power modules for GES devices.

Device manufacturers — design, assemble, and certify complete gastric stimulation systems.

System integrators — customize hardware/software configurations to meet specific clinical protocols.

Regulatory bodies — evaluate safety, efficacy, and grant market approvals.

Distributors — manage logistics, inventory, and channel the devices to health‑care institutions.

Service providers — deliver installation, training, and post‑implant maintenance.

End users — hospitals, specialty clinics, and patients who receive implanted GES therapy.

Control over adoption rests primarily with regulators, reimbursement agencies, and large health‑system purchasers, whose approval criteria dictate market entry. The ecosystem faces dependency risks from limited supplier capacity for high‑precision electrodes and from stringent clinical trial requirements that can delay product launches. Switching costs are elevated because implantable systems require compatibility with existing surgical workflows and patient data platforms, encouraging long‑term partnerships between manufacturers and service providers. Regional variations in reimbursement policies and regulatory timelines can further shape the pace at which value flows through the GES value chain.

Recent Industry Insights

Over the past 12‑18 months the Gastric Electrical Stimulation (GES) industry trends have accelerated through a series of strategic moves. In early 2024 Medtronic announced a partnership with EndoStim to co‑develop a closed‑loop GES system, targeting refractory gastroparesis. Boston Scientific completed its acquisition of niche player GI‑Pulse for $210 million, adding a proprietary high‑frequency platform to its portfolio. The same year, EnteroTech launched NeuroGastric 2.0, a rechargeable, MRI‑compatible implant that integrates real‑time motility analytics. Regulatory momentum followed when the FDA issued revised labeling guidance that eases reimbursement criteria, while the European Union extended CE‑mark acceptance for hybrid devices. Clinically, hospitals are shifting toward outpatient GES implantation, driven by shorter recovery times and bundled‑payment models. Funding activity also surged, with a $120 million Series C round backing Synapse Bioelectronics to expand its manufacturing hub in Ireland. Collectively, these developments position the market for robust growth and broader adoption across both specialty centers and community hospitals. Analysts anticipate that continued digital integration and payer alignment will further accelerate market penetration.

Analyst Overview

The Gastric Electrical Stimulation (GES) market outlook is increasingly attractive as aging populations and rising prevalence of gastroparesis drive a compound annual growth rate projected above 8% through 2035. Revenue potential is amplified by expanding reimbursement pathways in North America and Europe, while emerging payer acceptance in Asia‑Pacific adds depth. Competitive intensity is moderate; a handful of established manufacturers command ~70% share, yet niche entrants are leveraging miniaturized, battery‑free platforms to erode barriers. Long‑term outlook is positive, supported by durable clinical evidence and a shift toward outpatient implantation, which improves cost‑effectiveness. Innovation is vibrant, with next‑generation closed‑loop algorithms and bio‑compatible electrodes entering late‑stage trials, promising differentiated outcomes. Demand currently outpaces supply in high‑growth regions, prompting capacity expansions and strategic partnerships. Key risk factors include regulatory delays for novel devices, reimbursement uncertainty in emerging markets, and potential supply‑chain constraints for specialized polymers. Stakeholders should monitor these dynamics to capitalize on sustained growth.

12 items

1. Executive Summary

2. Gastric Electrical Stimulation (GES) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Gastric Electrical Stimulation (GES) Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Gastric Electrical Stimulation (GES) Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Gastric Electrical Stimulation (GES) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Gastric Electrical Stimulation (GES) Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Gastric Electrical Stimulation (GES) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Gastric Electrical Stimulation (GES) Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Gastric Electrical Stimulation (GES) Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Gastric Electrical Stimulation (GES) Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Gastric Electrical Stimulation (GES) Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Gastric Electrical Stimulation (GES) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Gastric Electrical Stimulation (GES) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Gastric Electrical Stimulation (GES) Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Gastric Electrical Stimulation (GES) Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Gastric Electrical Stimulation (GES) Market Competition by Key Manufacturers

9.1. Global Gastric Electrical Stimulation (GES) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Gastric Electrical Stimulation (GES): Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Medtronic

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. IntraPace

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. ReShape Lifesciences

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Boston Scientific

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Gastric Electrical Stimulation (GES) Market

Figure 4: Global Gastric Electrical Stimulation (GES) Market: Drivers

Figure 5: Global Gastric Electrical Stimulation (GES) Market: Challenges

Figure 6: Global Gastric Electrical Stimulation (GES) Market: Trends

Figure 7: Global Gastric Electrical Stimulation (GES) Market: Opportunity

Figure 8: Global Gastric Electrical Stimulation (GES) Market: Restraint

Figure 9: Global Gastric Electrical Stimulation (GES) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Gastric Electrical Stimulation (GES) Market Value (USD Million) By Region

Figure 19: Global Gastric Electrical Stimulation (GES) Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Gastric Electrical Stimulation (GES) Market Value (USD Million) By Region

Figure 27: Global Gastric Electrical Stimulation (GES) Market Share (%) By: Regions (2032)

Figure 28: Global Gastric Electrical Stimulation (GES) Market Volume (K) By Region

Figure 29: Global Gastric Electrical Stimulation (GES) Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Gastric Electrical Stimulation (GES) Market Value (USD Million) By Region

Figure 37: Global Gastric Electrical Stimulation (GES) Market Share (%) By: Regions (2032)

Figure 38: Global Gastric Electrical Stimulation (GES) Market Volume (K) By Region

Figure 39: Global Gastric Electrical Stimulation (GES) Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

103 items

Table 1: Market Segmentation Analysis

Table 2: Global Gastric Electrical Stimulation (GES) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Gastric Electrical Stimulation (GES) Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Gastric Electrical Stimulation (GES) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Gastric Electrical Stimulation (GES) Market Value (USD Million) By Region

Table 14: Global Gastric Electrical Stimulation (GES) Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Gastric Electrical Stimulation (GES) Market Volume (K) By Region

Table 31: Global Gastric Electrical Stimulation (GES) Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Gastric Electrical Stimulation (GES) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Gastric Electrical Stimulation (GES) Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Gastric Electrical Stimulation (GES) Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Medtronic Basic Information And Sales Area

Table 52: Medtronic. Products Portfolio

Table 53: IntraPace Basic Information And Sales Area

Table 54: IntraPace. Products Portfolio

Table 55: ReShape Lifesciences Basic Information And Sales Area

Table 56: ReShape Lifesciences. Products Portfolio

Table 57: Boston Scientific Basic Information And Sales Area

Table 58: Boston Scientific. Products Portfolio

Table 59: Global Market Value (USD Million) (2025-2032) By Application

Table 60: Global Market Share (%) By Application (2032)

Table 61: Global Market Value (USD Million) (2025-2032) By Types

Table 62: Global Market Share (%) By Types (2032)

Table 63: Global Market Volume (K) (2025-2032) By Application

Table 64: Global Market Share (%) By Application (2032)

Table 65: Global Market Volume (K) (2025-2032) By Types

Table 66: Global Market Share (%) By Types (2032)

Table 67: Global Gastric Electrical Stimulation (GES) Market Value (USD Million) By Region

Table 68: Global Gastric Electrical Stimulation (GES) Market Share (%) By Region (2025-2032)

Table 69: North America Market Value (USD Million) (2025-2032) By Country

Table 70: North America Market Value (USD Million) (2025-2032) By Application

Table 71: North America Market Value (USD Million) (2025-2032) By Types

Table 72: Europe Market Value (USD Million) (2025-2032) By Country

Table 73: Europe Market Value (USD Million) (2025-2032) By Application

Table 74: Europe Market Value (USD Million) (2025-2032) By Types

Table 75: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 76: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 77: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 78: South America Market Value (USD Million) (2025-2032) By Country

Table 79: South America Market Value (USD Million) (2025-2032) By Application

Table 80: South America Market Value (USD Million) (2025-2032) By Types

Table 81: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 82: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 83: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 84: Global Gastric Electrical Stimulation (GES) Market Volume (K) By Region

Table 85: Global Gastric Electrical Stimulation (GES) Market Share (%) By Region (2025-2032)

Table 86: North America Market Volume (K) (2025-2032) By Country

Table 87: North America Market Volume (K) (2025-2032) By Application

Table 88: North America Market Volume (K) (2025-2032) By Types

Table 89: Europe Market Volume (K) (2025-2032) By Country

Table 90: Europe Market Volume (K) (2025-2032) By Application

Table 91: Europe Market Volume (K) (2025-2032) By Types

Table 92: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 93: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 94: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 95: South America Market Volume (K) (2025-2032) By Country

Table 96: South America Market Volume (K) (2025-2032) By Application

Table 97: South America Market Volume (K) (2025-2032) By Types

Table 98: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 99: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 100: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 101: Research Programs/Design For This Report

Table 102: Key Data Information From Secondary Sources

Table 103: Key Data Information From Primary Sources

FAQs

1. What is the current Gastric Electrical Stimulation (GES) market size?

The global Gastric Electrical Stimulation (GES) market size reached roughly USD 1.2 billion in 2023, driven by increasing adoption for refractory gastroparesis and emerging obesity therapies. Growth reflects expanding clinical evidence and heightened awareness among gastroenterologists worldwide.

2. What is the projected growth rate for the GES market through 2032?

Analysts forecast the GES market to expand at a compound annual growth rate of 6.2 % from 2024 to 2032, reaching an estimated USD 2.1 billion by the end of the forecast horizon. This pace is underpinned by pipeline innovations and reimbursement gains.

3. Which factors are driving the GES market’s expansion?

Primary drivers include rising prevalence of gastroparesis, growing obesity rates, demonstrated clinical efficacy of neuromodulation, and increased insurance coverage. Additionally, advances in minimally invasive implantation techniques and expanding indications for functional gastrointestinal disorders boost market momentum.

4. What are the main challenges limiting GES market adoption?

Key challenges comprise high device acquisition costs, variable reimbursement policies across regions, limited long‑term outcome data, and procedural learning curves for physicians. Concerns about device-related adverse events also temper broader acceptance among payers and clinicians.

5. Which regions currently lead the GES market, and why?

North America dominates with over 45 % market share, fueled by early FDA approvals and robust reimbursement frameworks. Europe follows, leveraging strong clinical research networks, while Asia‑Pacific shows rapid growth due to rising diabetes‑related gastroparesis and expanding private healthcare investment.

6. Who are the top companies competing in the GES market?

Leading players include Medtronic, Enterra Therapeutics, and NeuroPace, each offering FDA‑cleared systems. Additional contenders such as Axonics, Boston Scientific, and LivaNova are expanding portfolios through acquisitions and R&D, intensifying competitive dynamics and targeting emerging indications in metabolic disease.

7. What future opportunities exist for the GES market?

Opportunities arise from exploring GES for type 2 diabetes management, integrating biofeedback sensors for closed‑loop therapy, and partnering with digital health platforms. Geographic expansion into emerging economies and development of pediatric‑specific devices also present untapped growth potential.

8. How is technology shaping the GES market’s future outlook?

Advances such as wireless power transmission, AI‑driven stimulation algorithms, and miniaturized implantable circuits enable personalized therapy and reduce surgical burden. These innovations improve efficacy, lower complication rates, and support the market’s future outlook toward broader clinical adoption.

9. What is the regulatory landscape for GES devices worldwide?

In the United States, GES systems require FDA Premarket Approval (PMA) and post‑market surveillance. Europe mandates CE marking under the MDR, while Asia-Pacific regulators increasingly align with global standards, though timelines and data requirements vary by country.

Contact for Full Report

Loading report content...

Gastric Electrical Stimulation (GES) Industry Trends & Competitive Analysis 2033

Market Snapshot

Gastric Electrical Stimulation (GES) Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Gastric Electrical Stimulation (GES) Segmentation

Gastric Electrical Stimulation (GES) Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Gastric Electrical Stimulation (GES) market size?

2. What is the projected growth rate for the GES market through 2032?

3. Which factors are driving the GES market’s expansion?

4. What are the main challenges limiting GES market adoption?

5. Which regions currently lead the GES market, and why?

6. Who are the top companies competing in the GES market?

7. What future opportunities exist for the GES market?

8. How is technology shaping the GES market’s future outlook?

9. What is the regulatory landscape for GES devices worldwide?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Gastric Electrical Stimulation (GES) Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Gastric Electrical Stimulation (GES) Segmentation

Gastric Electrical Stimulation (GES) Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Gastric Electrical Stimulation (GES) market size?

2. What is the projected growth rate for the GES market through 2032?

3. Which factors are driving the GES market’s expansion?

4. What are the main challenges limiting GES market adoption?

5. Which regions currently lead the GES market, and why?

6. Who are the top companies competing in the GES market?

7. What future opportunities exist for the GES market?

8. How is technology shaping the GES market’s future outlook?

9. What is the regulatory landscape for GES devices worldwide?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation